| Title: | COVID-19 vaccination hesitancy among people with chronic neurological disorders : a position paper |
|---|
| Authors: | ID Rakuša, Martin (Author)
ID Öztürk, Serefnur (Author)
ID Moro, Elena (Author)
ID Helbok, Raimund (Author)
ID Bassetti, Claudio (Author)
ID Beghi, Ettore (Author)
ID Bereczki, Daniel (Author)
ID Bodini, Benedetta (Author)
ID Di Liberto, Giovanni (Author)
ID Jenkins, Tom (Author), et al. |
|---|
| Files: |  Rakusa-2022-COVID-19_vaccination_hesitancy_amo.pdf (1,02 MB)
MD5: AEEB9CC074F4F26A358E98FDC412BC39
 https://doi.org/10.1111/ene.15368
|
|---|
| Language: | English |
|---|
| Work type: | Scientific work |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: | MF - Faculty of Medicine
|
|---|
| Abstract: | Background and purpose
Health risks associated with SARS-CoV-2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID-19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID-19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID-19 pandemic but puts individual lives at risk, as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID-19 course.
Methods
In this position paper, the NeuroCOVID-19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage, and formulates strategies to overcome vaccination hesitancy. A survey among the Task Force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation.
Results
The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS-CoV-2 vaccination. The prevailing concerns included the chance of worsening the pre-existing neurological condition, vaccination-related adverse events, and drug interaction.
Conclusions
The EAN NeuroCOVID-19 Task Force reinforces the key role of neurologists as advocates of COVID-19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID-19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, its concerns, and the emergence of potential safety signals. |
|---|
| Keywords: | advocacy, COVID-19, infectious disease prevention, neurological disorders, SARS-CoV-2, vaccination, vaccine skepticism |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Submitted for review: | 12.04.2022 |
|---|
| Article acceptance date: | 15.04.2022 |
|---|
| Publication date: | 23.04.2022 |
|---|
| Publisher: | Blackwell Science |
|---|
| Year of publishing: | 2022 |
|---|
| Number of pages: | Str. 2163-2172 |
|---|
| Numbering: | Letn. 29, Št. 8 |
|---|
| PID: | 20.500.12556/DKUM-89282  |
|---|
| UDC: | 616.8 |
|---|
| ISSN on article: | 1468-1331 |
|---|
| COBISS.SI-ID: | 108168963 |
|---|
| DOI: | 10.1111/ene.15368 |
|---|
| Publication date in DKUM: | 02.07.2024 |
|---|
| Views: | 387 |
|---|
| Downloads: | 15 |
|---|
| Metadata: |    |
|---|
| Categories: | Misc.
|
|---|
|
:
|
Copy citation |
|---|
| | | | Average score: | (0 votes) |
|---|
| Your score: | Voting is allowed only for logged in users. |
|---|
| Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
